UJCR; 2024, Vol. 4, Issue 3


Subject of the article

Severe case of community-acquired pneumonia complicated by acute respiratory distress syndrome and sepsis (22-24)

Authors

Usmanov BZh

Institution

Samarkand State Medical University

Abstract

Abstract. Acute pneumonia remains a significant global health concern, causing substantial morbidity and mortality. The social component of this problem is that it occurs in childhood and adulthood more and more often. Although this problem has been fairly well studied, there are still a number of questions that need to be answered. In modern literature, there is the concept of atypical pneumonia, which is interpreted differently by different authors and communities. Some authors affirm that this is pneumonia caused by a certain group of pathogens, while others claim that this is a form of pneumonia that is atypically manifested during radiation studies. In addition, there are conclusions that atypical pneumonia is a fast-acting form of pneumonia, leading to organ failure in a short period of time, so to speak, a fulminant form. In this article, we present a clinical case of a young patient without risk factors, in whom signs of community-acquired pneumonia developed within 12 hours before admission to the hospital emergency room and within 24 hours led to sepsis and multiple organ failure. At the time of admission, the patient was diagnosed with acute heart failure, which led primarily to misconception. Hemodynamic instability in this case did not allow routine computed tomography of the chest to be performed to exclude pulmonary pathology. After this observation, we are more inclined to designate the fast-moving form as atypical pneumonia. Such cases are not often encountered in the daily practice of doctors and, unfortunately, comprehensive methods of diagnosis and treatment have not been fully developed.

Key words

atypical pneumonia, fulminant pneumonia, atypical community-acquired pneumonia, community-acquired pneumonia.

Literature

1. Kochanek KD, Murphy SL, Xu J, Tejada-Vera B. National vital statistics reports. Natl Vital Stat Rep. 2011;59(4):1-102. 2. Ramirez JA, Wiemken TL, Peyrani P, et al. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017;65(11):1806-1812. 3. Chalmers JD, Pletz MW, Alberti S, eds. Epidemiology of CAP in Europe. Community-Acquired Pneumonia: Eur Respir Monogr. 2014;63:1838. 4. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459-1544. 5. World Health Organization. The top ten causes of death. Available at: http://www.who.int/mediacentre/factsheets/fs310. pdf. Published September 4, 2013. Accessed October 2023. 6. Waterer GW, Kessler LA, Wunderink RG. Medium-term survival after hospitalization with community-acquired pneumonia. Am J Respir Crit Care Med. 2004;169:910-914. 7. Garcia-Vidal C, Fernández-Sabé N, Carratalà J, et al. Early mortality in patients with community-acquired pneumonia: causes and risk factors. Eur Respir J. 2008;32(3):733-739. 8. Viasus D, Cillóniz C, Cardozo CG, et al. Early, short and long-term mortality in community-acquired pneumonia. Ann Res Hosp. 2018;2(5):1-13. 9. Murdoch DR, Chambers ST. Atypical pneumonia: time to breathe new life into a useful term? Lancet Infect Dis. 2009;9:512-519. 10. Basarab M, Macrae MB, Curtis CM. Atypical pneumonia. Curr Opin Pulm Med. 2014;20(3):247-251. doi:10.1097/ MCP.0000000000000048. 11. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163(7):1730-1754. 12. Dueck NP, Epstein S, Franquet T, Moore CC, Bueno J. Atypical pneumonia: definition, causes, and imaging features. RadioGraphics. 2021;41(3):720-741.